Clinical Updates and Cost Management Strategies in Treating Idiopathic Pulmonary Fibrosis

Date:               Wednesday, May 1, 2019

Location:         Wynn and Encore Hotels
3131 S Las Vegas Boulevard
Las Vegas, Nevada 89109

Room: Lafleur

Time:               12:00 pm – 1:30 pm
                        *Lunch will be available

Program Description
Clinical management of idiopathic pulmonary fibrosis (IPF) is complex. Patients have a poor prognosis, with estimated life expectancies ranging from 3 to 5 years. Evolving knowledge of the pathogenesis of IPF has shown that the disease is linked to a dysregulated wound-healing cascade and fibroproliferation, which has allowed for the development of medications, such as nintedanib and pirfenidone, with different mechanisms to slow disease progression. As additional data become available, specialty pharmacists must be able to recognize the strengths and limitations of new and emerging therapies to make cost-effective and clinically appropriate treatment decisions. Additionally, pharmacists can improve medication adherence by educating patients and caregivers about drug administration and handling, adverse effects, and the potential for drug interactions.

Educational Objectives
  • Identify evidence-based treatment plans for idiopathic pulmonary fibrosis (IPF)
  • Examine recent efficacy and safety data in IPF treatment
  • Explain the use of cost-effectiveness data to develop IPF management plans

Faculty Presenters

Lisa H. Lancaster, MD
Associate Professor of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

Geoffrey C. Wall, PharmD, FCCP, BCPS, CGP
Professor of Clinical Sciences
Drake University College of Pharmacy and Health Sciences
Internal Medicine Clinical Pharmacist
Iowa Methodist Medical Center
Consulting Partner
Medical Intelligence Group, PLLC
Des Moines, Iowa

This activity is supported by an educational grant from Genentech.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity number 0290-0000-19-048-L01-P. The activity is available for CE credit for May 1, 2019.

Obtaining Credit:
All participants who attended the live symposium need to log on to their Pharmacy Times Continuing Education™ account on to complete an online evaluation form and request their credit. Detailed instructions on obtaining credit will be provided at the session. Credit must be requested no later than July 1, 2019.